AMH and myeloid sarcoma: Previously, Graves et al. reported that ovarian aging, as indicated by lower AMH levels, was associated with both clinical and radiographic metrics of MS severity, as shown by the relationship with lower grey matter volume after adjustments for chronological age and disease duration (18).